Cell-permeable iron inhibits vascular endothelial growth factor receptor-2 signaling and tumor angiogenesis
Metrics: PDF 860 views | HTML 916 views | ?
Devika Kir1,2, Manju Saluja1, Shrey Modi2, Annapoorna Venkatachalam1, Erica Schnettler1, Sabita Roy1,2,3, Sundaram Ramakrishnan1,3
1Department of Pharmacology, Masonic Comprehensive Cancer Center, Minneapolis, MN 55455, USA
2Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
3Present address: Department of Surgery, University of Miami, FL 33136, USA
Sundaram Ramakrishnan, email: firstname.lastname@example.org
Keywords: cell-permeable iron, ferric ammonium citrate, angiogenesis, vascular endothelial growth factor, receptor phosphorylation
Received: March 25, 2016 Accepted: July 19, 2016 Published: August 30, 2016
Angiogenesis is important for tumor growth and metastasis. Hypoxia in tumors drives this angiogenic response by stabilizing Hypoxia Inducible Factors (HIF) and target genes like Vascular Endothelial Growth Factor (VEGF). HIF stability is regulated by Prolylhydroxylases (PHD)-mediated modification. Iron is an important cofactor in regulating the enzymatic activity of PHDs. Reducing intracellular iron, for instance, mimics hypoxia and induces a pro-angiogenic response. It is hypothesized that increasing the intracellular iron levels will have an opposite, anti-angiogenic effect. We tested this hypothesis by perturbing iron homeostasis in endothelial cells using a unique form of iron, Ferric Ammonium Citrate (FAC). FAC is a cell-permeable form of iron, which can passively enter into cells bypassing the transferrin receptor mediated uptake of transferrin-bound iron. Our studies show that FAC does not decrease the levels of HIF-1α and HIF-2α in endothelial cells but inhibits the autocrine stimulation of VEGF-Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) system by blocking receptor tyrosine kinase phosphorylation. FAC inhibits VEGF-induced endothelial cell proliferation, migration, tube formation and sprouting. Finally, systemic administration of FAC inhibits VEGF and tumor cell-induced angiogenesis in vivo. In conclusion, our studies show that cell-permeable iron attenuates VEGFR-2 mediated signaling and inhibits tumor angiogenesis.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.